Zuellig Pharma Korea grapples with tougher domestic market

Following revelation of Zuellig Pharma Korea's two-year consecutive deficits, there are lingering concerns about its successful presence (or viability) in the domestic market, as its financial index have successfully been deteriorating albeit increasing sales volume per year. It is presumed that a number of factors have contributed to the increasing deficits of the company. Details:

1) Protr...